BEGIN:VCALENDAR
PRODID:-//github.com/ical-org/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Join us for a dean’s workshop on advanced genetic therapies\, 
 titled “End-to-End Precision Genetic Therapies: From Emerging Technologie
 s to Patient Delivery” on Monday\, Nov. 2\, from 1 - 4:30 p.m . This work
 shop brings together leaders from across Yale and the broader precision g
 enetics community to discuss the latest advances in the field. Our scient
 ists and clinicians\, together with representatives from the NIH\, regula
 tory and biopharmaceutical sectors\, and the patient advocacy community\,
  will discuss next-generation gene-editing and delivery platforms and the
 ir application in the clinic across rare genetic disorders. The event wil
 l feature two keynote addresses:P.J. Brooks\, PhD \, acting director of t
 he Division of Rare Diseases Research Innovation at the NIH’s National Ce
 nter for Advancing Translational Sciences\, and co-chair of the NIH’s Bes
 poke Gene Therapy Consortium and Somatic Cell Genome Editing Programs\, w
 ill open the workshop on the future of gene editing. Peter Marks\, MD\, P
 hD \, our former colleague and a former director of the FDA’s Center for 
 Biologics Evaluation and Research\, now senior vice president\, Molecule 
 Discovery and head of infectious disease at Eli Lilly\, will deliver the 
 closing keynote on the evolving regulatory landscape.The afternoon conclu
 des with a panel discussion\, “Precision Genetic Medicine: From Promise t
 o Practice\,” convening regulatory\, clinical\, and patient-advocacy lead
 ers to explore the infrastructure\, regulatory\, and health-system challe
 nges of bringing these therapies to patients.This hybrid event\, hosted b
 y the School of Medicine dean’s office\, will take place in person in Bra
 dy Auditorium\, B131 (310 Cedar Street)\, and via Zoom. WELCOME\, 1 – 1:0
 5 PM Nancy J. Brown\, MD\, Jean and David W. Wallace Dean of Medicine and
  C.N.H. Long Professor of Internal Medicine\, Yale School of Medicine GEN
 E EDITING DELIVERY TECHNOLOGIES\, 1:05 – 2:25 PM Moderator: Monkol Lek\, 
 PhD\, Associate Professor of Genetics\, Yale School of MedicineOPENING KE
 YNOTE: THE NIH SOMATIC CELL GENOME EDITING PROGRAM AND THE FUTURE OF GENE
  EDITING AS A THERAPEUTIC PLATFORM\, 1:05 – 1:45 PMP.J. Brooks\, PhD\, Ac
 ting Director\, Division of Rare Diseases Research Innovation\, National 
 Center for Advancing Translational Sciences\, NIH\; and Co-Chair of the N
 IH’s Bespoke Gene Therapy Consortium and Somatic Cell Genome Editing Prog
 ramsNON-VIRAL DELIVERY OF GENE THERAPY: POLYMERIC NANOPARTICLES\, 1:45 - 
 2:05 PMMark W. Saltzman\, PhD\, Sterling Professor of Biomedical Engineer
 ing\; Faculty Director\, Center for Engineering Innovation and Design\; a
 nd Deputy Dean for Academic Affairs\, Yale Engineering\; and Head\, Jonat
 han Edwards College\, Yale UniversityNON-VIRAL DELIVERY OF GENE THERAPY: 
 LIPID NANOPARTICLES AND STEP\, 2:05 - 2:25 PMJiangbing Zhou\, PhD\, Nixdo
 rff-German Professor of Neurosurgery\, Yale School of Medicine\; and Prof
 essor of Biomedical Engineering\, Yale EngineeringNETWORKING BREAK\, 2:25
  - 2:40 PM GENE EDITING: PATH TO THE CLINIC\, 2:40 - 4:00 PM Moderator: P
 eter Glazer\, MD\, PhD\, Robert E. Hunter Professor and Chair of Therapeu
 tic Radiology\, and Professor of Genetics\, Yale School of MedicineINNOVA
 TIVE GENOME AND EPIGENOME EDITING–BASED THERAPIES FOR NEUROGENETIC DISORD
 ERS\, 2:40 - 3:00 PMYong-Hui Jiang\, MD\, PhD\, Professor of Genetics\, o
 f Pediatrics\, and of Obstetrics\, Gynecology\, and Reproductive Sciences
 \, and Dorys McConnell Duberg Professor of Neuroscience\, Yale School of 
 Medicine\; and Chief of Medical Genetics\, Yale New Haven Health System G
 ENE-EDITING PLATFORMS TO ADDRESS CYSTIC FIBROSIS\, 3:00 - 3:20 PMMarie Eg
 an\, MD\, Professor of Pediatrics and of Cellular and Molecular Physiolog
 y\; Director\, Cystic Fibrosis Center\; Vice Chair of Research\, Departme
 nt of Pediatrics\, Yale School of Medicine\; and Chief\, Pediatric Pulmon
 ary\, Allergy\, and Sleep Medicine\; Yale New Haven Health System CLOSING
  KEYNOTE: A POTENTIAL REGULATORY FRAMEWORK FOR GENE-EDITING THERAPIES\, 3
 :20 - 4:00 PMPeter Marks\, MD\, PhD\, Senior Vice President\, Molecule Di
 scovery and Head of Infectious Disease\, Eli Lilly and Company PANEL: PRE
 CISION GENETIC MEDICINE: FROM PROMISE TO PRACTICE\, 4:00 - 4:25 PM Modera
 tor: Marie Egan\, MD\, Professor of Pediatrics and of Cellular and Molecu
 lar Physiology\; Director\, Cystic Fibrosis Center\; Vice Chair of Resear
 ch\, Department of Pediatrics\, Yale School of Medicine\; and Chief\, Ped
 iatric Pulmonary\, Allergy\, and Sleep Medicine\; Yale New Haven Health S
 ystem A DISCUSSION OF INFRASTRUCTURE\, REGULATION\, AND CLINICAL SYSTEMSP
 anelists: Allyson Berent\, DVM\, Dipl. ACVIM\, Chief Science Officer\, Fo
 undation for Angelman Syndrome Therapeutics\; and Chief Development Offic
 er\, AS²BioBeth Heinz\, MHA\, MSW\, Senior Vice President\, Women’s & Chi
 ldren’s Services\, Yale New Haven HospitalLakshmanan Krishnamurti\, MD\, 
 Professor of Pediatrics\, Yale School of Medicine and Chief\, Section of 
 Pediatric Hematology/Oncology/BMT\, Yale New Haven Health SystemPeter Mar
 ks\, MD\, PhD\, Senior Vice President\, Molecule Discovery and Head of In
 fectious Disease\, Eli Lilly and CompanyCLOSING REMARKS\, 4:25 – 4:30 PM 
 Nancy J. Brown\, MDThe workshop is being recorded and will be available o
 nline after the event at https://medicine.yale.edu/about/deanoffice/works
 hop\n\nSpeakers:\nNancy Brown\; Monkol Lek\; PJ Brooks\, PhD\; W. Mark Sa
 ltzman\; Jiangbing Zhou\; Peter Glazer\; Yong-Hui Jiang\; Marie Egan\; Pe
 ter Marks\, MD\, PhD\; Allyson Berent\, DVM\; Beth Heinz\, MHA\, MSW\; La
 kshmanan Krishnamurti\n\nAdmission:\nFree\n\nDetails URL:\nhttps://medici
 ne.yale.edu/event/deans-workshop-precision-genetic-therapies-nov-2-2026/\
 n
DTEND;TZID=America/New_York:20261102T170000
DTSTAMP:20260930T223814Z
DTSTART;TZID=America/New_York:20261102T130000
LOCATION:URL: https://yale.zoom.us/j/93614615801
SEQUENCE:0
STATUS:Confirmed
SUMMARY:Dean's Workshop
UID:108029e0-a72c-4009-9128-bd8d8917178e
END:VEVENT
END:VCALENDAR
